Liver Metastases of Unknown Primary: Malignant Melanoma

  • Bostanci O
  • Kartal K
  • Battal M
N/ACitations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

According to the National Cancer Institute’s (NCI) data, the increase in the number of patients diagnosed with malignant melanoma was found to be at a higher rate than the current increase in all other types of cancer (Jemal et al., 2008). Early diagnosis, appropriate surgical treatment, and chemotherapy have positive impacts on the course of the disease but despite these developments on the treatment, current prognosis of metastatic malignant melanoma prognosis is still extremely poor. Life expectancy in patients with metastatic disease is between 2 and 8 months. The 5-year disease-free survival rate is identified in only 5% of the patients (Leong, 2003) (Kirkwood et al., 1996). In this study, we try to report a patient with metastatic malignant melanoma and give recent informations about the liver metastases of malignant melanoma.

Cite

CITATION STYLE

APA

Bostanci, O., Kartal, K., & Battal, M. (2014). Liver Metastases of Unknown Primary: Malignant Melanoma. Case Reports in Hepatology, 2014, 1–4. https://doi.org/10.1155/2014/131708

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free